A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or neuropathy, in cancer survivors, according to a study by researchers at The University of Texas MD Anderson Cancer Center. The study is the largest, to date, to determine the benefits of neurofeedback in cancer survivors.
Chronic chemotherapy-induced peripheral neuropathy (CIPN) is caused...
While many times, the achievements of senior faculty members receive the greatest attention, MD Anderson is also taking steps to highlight...
In 2011, the MD Anderson Cancer Center received a $150 million gift — the largest in the history of the institution — from the Khalifa Bin...
The goal of harnessing the power of one's immune system to target and kill cancer cells just got a boost. New research from MD Anderson has yielded promising insights into a protein known as PDL1, which was found to be expressed in 20% of triple negative breast tumors.
Triple-negative disease is more aggressive than other types of breast cancer and is not fueled by female hormones estrogen and progesterone or by the cancer growth-promoting...
Oral cancer patients with tumors at the back of the throat are half as likely to require a feeding tube when treated with intensity modulated...
New MD Anderson research published in JAMA Otolaryngology Head and Neck Surgery indicates that oral exercises help patients maintain their...
MD Anderson scientists have found a molecular signaling pathway that connects two known contributors to cancer cell growth and survival. They...
By Leslie Loddeke, Publications Coordinator, Melanoma Medical Oncology Department
MD Anderson Melanoma Medical Oncology...
Lynda Chin, M.D., professor and chair of MD Anderson's Department of Genomic Medicine and scientific director of the Institute for Applied...
Andrew Schorr is a pioneer in health communications and patient education and, along the way, became a patient himself. Andrew was diagnosed...